<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03845634</url>
  </required_header>
  <id_info>
    <org_study_id>10-27</org_study_id>
    <nct_id>NCT03845634</nct_id>
  </id_info>
  <brief_title>Validation of a Non-Motor Fluctuation Assessment Instrument (NoMoFA) for Parkinson's Disease</brief_title>
  <official_title>Validation of a Non-Motor Fluctuation Assessment Instrument (NoMoFA) for Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistive Technology Clinic, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rush University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Parkinson Study Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistive Technology Clinic, Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators have developed a comprehensive questionnaire that assesses the presence of
      non-motor fluctuations (NMFs) in individuals with Parkinson's disease (PD). To date, 189
      participants with PD have been assessed for preliminary data analysis prior to developing the
      penultimate version. At this time the objectives are to: (i) assess the scale's internal
      consistency and item-to-total correlations; (ii) assess test-retest reliability; (iii) use
      factor analysis and reliability measures to guide item reduction; (iv) assess construct
      validity; and (v) assess the scales ability to discriminate between static non-motor symptoms
      and non-motor symptoms which fluctuate (vi) estimate the relative distribution of cognitive,
      psychiatric, autonomic, sleep and sensory NMFs in PD patients with motor fluctuations and
      their impact on quality of life in Parkinson's disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 13, 2018</start_date>
  <completion_date type="Actual">September 11, 2019</completion_date>
  <primary_completion_date type="Actual">September 11, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cronbach's Alpha</measure>
    <time_frame>Baseline</time_frame>
    <description>alpha 0 - 1.0</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Item-to-total correlation</measure>
    <time_frame>Baseline</time_frame>
    <description>correlation -1.0 - 1.0</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inter-rater reliability</measure>
    <time_frame>1 week after Baseline</time_frame>
    <description>kappa 0 - 1.0</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concurrent validity</measure>
    <time_frame>Baseline</time_frame>
    <description>correlation -1.0 - 1.0</description>
  </primary_outcome>
  <enrollment type="Actual">202</enrollment>
  <condition>Parkinson Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals, both men and women, who have been diagnosed with idiopathic Parkinson's
        Disease and have motor and non-motor fluctuating symptoms are invited to participate in the
        study. To ensure a representative sample, subjects spanning the disease spectrum will be
        equally represented in terms of mild, moderate and advanced symptoms of PD.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with Idiopathic Parkinson's Disease (according to the United Kingdom
             Parkinson's Disease Society Brain Bank clinical diagnostic criteria)

          -  Stage of symptoms is mild, moderate or severe as per the Hoehn &amp; Yahr scale

          -  Have motor fluctuations

          -  Have non-motor fluctuations

        Exclusion Criteria:

          -  Atypical Parkinsonism

          -  Lack of motor fluctuations

          -  Lack of English language proficiency in either subject or caregiver
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Galit Kleiner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistive Technology Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistive Technology Clinic</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6A 2E1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 7, 2019</study_first_submitted>
  <study_first_submitted_qc>February 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2019</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non-motor fluctuation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

